Jade Biosciences, Inc. (JBIO)
Nasdaq: JBIO · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 6, 2026 | Mar 27, 2025 | Mar 25, 2024 | Mar 29, 2023 | Mar 30, 2022 | · |
| Research and development | 93,121 | 53,187 | 64,219 | 38,622 | 14,987 | 7,940 |
| General and administrative | 20,421 | 21,409 | 17,190 | 14,615 | 8,035 | 949 |
| Total operating expenses | 113,542 | 74,596 | 81,409 | 53,237 | 23,022 | 8,889 |
| Operating income | -113,542 | -74,596 | -81,409 | -53,237 | -23,022 | -8,889 |
| Interest expense | · | · | · | · | · | 75 |
| Interest income (expense), net | 7,782 | 5,042 | 5,945 | 1,830 | 65 | -75 |
| Other income (expense), net | -8 | -19 | -1r | 1,751 | 62 | -722 |
| Total non-operating income (expense) | -13,810 | 5,023 | 5,944 | · | · | · |
| Income before income taxes | -127,352 | -69,573 | -75,465 | -51,486 | -22,960 | -9,611 |
| Income tax expense | 58 | 55 | 56 | 25 | 3 | · |
| Net income including non-controlling interests | -127,410 | -69,628 | -75,521 | -51,511 | -22,963 | -9,611 |
| Net income | -127,410 | -69,628 | -75,521 | -51,511 | -22,963 | -9,611 |
| Net income to common shareholders | -100,136 | -69,628 | -75,521 | -51,511 | -22,985 | -9,764 |
| Earnings per share, basic | -3.19 | -2.44 | -2.87 | -2.10 | -1.87 | · |
| Earnings per share, diluted | -3.19 | -2.44 | -2.87 | -2.10 | -1.87 | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.87 | -40.31 |
| Weighted average shares, basic | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · |
| Weighted average shares, diluted | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 12,293,629 | 242,232 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted